DJO’s Share-Taking Momentum Undercut by COVID-19

DJO's logo

DJO reported 1Q20 orthopedic revenue of USD $89.3 million, -0.6% vs. 1Q19. Per company leadership, DJO took share and had double-digit growth into March before COVID-19’s impact on elective procedures. The company observed a -90% decrease in procedures during April, but saw sales levels improve on a weekly basis recently. DJO’s internal...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us